Product Information

Registration Status: Active

TALZENNA CAPSULE 0.25MG is approved to be sold in Singapore with effective from 2020-05-22. It is marketed by PFIZER PTE LTD, with the registration number of SIN15944P.

This product contains Talazoparib 0.25 mg in the form of CAPSULE. It is approved for ORAL use.

This product is manufactured by Excella GmbH & Co. KG in GERMANY.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.



Talazoparib is under investigation for the treatment of Childhood Solid Tumors.

Active Ingredient/Synonyms

Talazoparib | Talazoparib |

Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.


  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank